Syngene schedules September results: what June loss means for Syngene stock

Published on 10/19/2026 at 03:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The June 2026 quarter brought a 29.03 percent revenue drop to INR 736.00 crore. For Syngene stock, net loss reached INR 9.00 crore after INR 147.90 crore profit.

Upcoming results frame the comparison

Syngene's board is due to review September 30, 2026 results on October 27, 2026.
Revenue fell 29.03 percent to INR 736.00 crore in the June 2026 quarter.
Net loss was INR 9.00 crore after INR 147.90 crore net profit in March 2026.

Syngene, INE398R01022, Illustration mit AI erstellt.

Syngene (ISIN INE398R01022) recorded revenue of INR 736.00 crore and a net loss of INR 9.00 crore in the quarter ended June 30, 2026, according to Way2wealth. The company is preparing to publish results for the quarter and half year ended September 30, 2026.

June results reset the comparison

Revenue fell 29.03 percent from INR 1,036.50 crore in the March 2026 quarter to INR 736.00 crore in June. Net profit also moved from INR 147.90 crore to a net loss of INR 9.00 crore over the same periods, while the profit-after-tax margin fell from 14.26 percent to minus 1.22 percent.

The figures make the upcoming report important for assessing whether the June outcome was temporary or reflects weaker operating leverage. Syngene describes itself as an integrated research, development and manufacturing organization serving pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical customers, according to the company's Syngene investor page.

What does the June loss mean?

The immediate answer is visible in the margin comparison. Operating profit before other income, interest, exceptional items and tax was negative INR 21.40 crore in June 2026, against INR 191.90 crore in March 2026, according to Way2wealth. That reversal puts the next report's revenue, operating profit and margin trends ahead of broader business descriptions for the stock.

Two dates define the next test

Tulsian AI reported on October 8, 2026 that Syngene's board was scheduled to consider the unaudited results on October 27, 2026. The same notice said the results would cover the quarter and half year ended September 30, 2026.

A separate Tulsian AI report dated October 17, 2026 scheduled the post-results conference call for October 28, 2026, from 9:00 a.m. to 10:00 a.m. IST. The call is intended to discuss the September quarter results with analysts and investors.

Syngene enters a results checkpoint

The September report will show whether revenue has recovered from INR 736.00 crore and whether profitability has moved above the June margin of minus 1.22 percent. For investors, those two operating measures provide the clearest test of the company's near-term earnings trajectory.